Severe preeclampsia and gene mutation HNF4A (MODY1): а case report
Preeclampsia is an obstetric complication that is becoming a major cause of maternal and perinatal morbidity and mortality. The rate of preeclampsia in diabetes mellitus is 3 to 5-fold higher than in the population. Heparin is used for prevention of preeclampsia due to its experimentally shown impor...
Main Authors: | V. M. Gur'eva, M. E. Yablokova, F. F. Burumkulova, N. A. Zubkova, A. N. Tyul'pakov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
MONIKI
2018-08-01
|
Series: | Alʹmanah Kliničeskoj Mediciny |
Subjects: | |
Online Access: | https://www.almclinmed.ru/jour/article/view/831 |
Similar Items
-
Clinical Utility of Weekly Laboratory Testing in the Outpatient Management of Preeclampsia and Gestational Hypertension
by: John A. Morgan, et al.
Published: (2020-01-01) -
Double Blind Clinical Trial the Comparison Aspirin Effect at Two Different Time of Circadian on 24 Hours Blood Pressure Mean Women at Preeclampsia Risk
by: KH Abdali, et al.
Published: (2011-04-01) -
Anti-Müllerian Hormone Levels in Preeclampsia: A Systematic Review of the Literature
by: Vasilios Pergialiotis, et al.
Published: (2018-06-01) -
Maternal Periodontitis, Preeclampsia and Adverse Pregnancy Outcomes
by: Pourandokht Afshari, et al.
Published: (2013-07-01) -
Maternal Omega-3 Nutrition, Placental Transfer and Fetal Brain Development in Gestational Diabetes and Preeclampsia
by: Prasad P. Devarshi, et al.
Published: (2019-05-01)